Moreover, Williams et al. [8] demonstrated that the activation of CAMK (CAMK II and CAMK IV) inhibits cell cycle progression in small cell lung carcinoma (SCLC) cells. The gene discussed is CAMK2G; the disease is small cell lung carcinoma.